Sheila Ann Mikhail, JD, MBA

Co-Founder, Executive Chair

Sheila Mikhail has over 20 years of biopharmaceutical leadership experience and was previously CEO and co-founder of Asklepios BioPharmaceutical, Inc. (AskBio), a company she started in 2001 and sold to Bayer for a total value of $4 billion in October 2020. She also served as CEO and co-founder of Bamboo Therapeutics, which in 20 months raised $50 million, advanced a therapeutic for giant axonal neuropathy into the clinic, completed pre-IND studies for a Duchenne muscular dystrophy therapeutic, and built a GMP manufacturing facility. Bamboo was acquired by Pfizer in August 2016 in a deal valued at $827 million.